It’s always better to prevent a disease than to treat it. Vaccine prevent disease in the people who receive them. If enough people are vaccinated against a disease, then the disease cannot spread into their community. This is known as “Community Immunity.”

How do Vaccines Protect from Diseases?

When our immune system recognizes germs that enter the body as “foreign” invaders, or antigens it works not only to clear your body of that invader, but also creates a large number of memory cells that are specifically tuned to react to it. This protection is called immunity. Vaccines contain little bits of a disease – broken down and harless, and when injected, stimulate the production of antibodies. Through vaccination, we develop immunity without suffering from the actual diseases that vaccines prevent.

The Burden of Influenza

  • $24.6 billion in economic costs per year in the U.S. related to influenza and pneumonia

New vaccinations for emerging diseases and for infections that have been prevalent in the past offer hope for a healthier future for all.

What can I do?

RCR is currently seeking healthy volunteers for several investigational vaccine research studies. If you are over the age of 18, you could participate in one of the following investigational vaccine studies:

Featured

Rabies Vaccine

RCR is looking for flexible, healthy, young adults ages 18-40 for a Rabies vaccine trial. The purpose of this study is to determine the safety and effectiveness of the study rabies vaccine. Compensation is available for time and travel.

View Trial Details
Ages 18 – 40
Compensation* $3,160
Study Topics Vaccine

*Compensation for time and travel may be available to those who qualify.

Lyme Disease Vaccine for Kids

Rochester Clinical Research is currently enrolling patients between the ages of 5-17 years old for a Lyme Disease Vaccine research study.  The purpose of the study will be to evaluate the study vaccines effectiveness in children. This vaccine has been studied in adults prior to this study at RCR, and has been well tolerated.

View Trial Details
Ages 5 – 17
Compensation* $950
Study Topics Vaccine

*Compensation for time and travel may be available to those who qualify.

Men’s HPV Vaccine

The purpose of this research study is to determine the efficacy and safety of a 3-dose HPV vaccine in males between the ages of 20- 45. The vaccine aims to prevent HPV infection which are associated with oral cancer.

View Trial Details
Ages 20 – 45
Gender For male patients only
Compensation* $1,300
Study Topics Vaccine

*Compensation for time and travel may be available to those who qualify.

Featured

Coronavirus Vaccine Research Studies

Rochester Clinical Research has several coronavirus vaccine studies starting in 2020, and we will need the help of our community of volunteers.

View Trial Details
Ages 18+

Pneumonia Vaccine

Rochester Clinical Research is currently enrolling generally healthy individuals over 50 years old for a vaccine research study. The study will assess the safety and tolerability of two different dosage levels of study vaccine that may protect against a greater number of strains of pneumococcal disease. The study will last approximately 6 months with two visits to our office and 3 telephone calls.

View Trial Details
Ages 50+
Study Topics Vaccines

E. Coli Vaccine

Rochester Clinical Research is currently enrolling individuals over the age of 60 years old, who have had a UTI within the past 5 years for an E. coli vaccine research study. The study will evaluate the effectiveness of a stud vaccine that may protect against E. coli that could cause sepsis.

View Trial Details
Ages 60+
Study Topics Vaccine
Featured

Coronavirus Update

Rochester Clinical Research is following the ever-changing impact of the Coronavirus on a national level and in our local community. Please review our COVID Reopening Patient Access.

View Trial Details
Ages 18+
Study Topics Vaccine Interest

Chikungunya Vaccine

Rochester Clinical Research is participating in a study evaluating the immune response of a single dose of the study Chikungunya vaccine in healthy adults over the age of 18 years old.

View Trial Details
Ages 18+
Study Topics Vaccine